Why the study?
Does felodipine improve systemic and coronary hemodynamics in patients with coronary heart disease?
Does felodipine improve systemic and coronary hemodynamics in patients with coronary heart disease?
Felodipine improves systemic and coronary hemodynamics in patients with coronary heart disease primarily through afterload reduction.
Answers are grounded in this paper and cite their sources.
May support hemodynamic optimization in CHD via afterload reduction; leaves open effects on clinical outcomes.
The cardiovascular effects of felodipine, a new arteriolar vasodilator, were studied in 22 patients with coronary heart disease. There were significant falls in blood pressure and systemic vascular resistance of 16 and 38% respectively (P = 0.001), thus affecting after-load. Cardiac index and stroke index increased by 35 and 12% respectively. There was reflex tachycardia--from 75 +/- 3 to 85 +/- 3 b.p.m. (P = 0.005). Coronary sinus blood flow increased from 134 +/- 9 to 191 +/- 17 ml/min (P less than 0.005) and myocardial arterio-venous oxygen difference narrowed from 12.1 +/- 0.5 to 9.0 +/- 0.4 vols% (P less than 0.001) indicating less oxygen usage. With the heart rate held constant by atrial pacing, cardiac index and stroke index increased by 30 and 26% (P less than 0.001), whilst systolic blood pressure and systemic vascular resistance fell by 20 and 29% (P less than 0.001). This would suggest that the improved haemodynamics were largely secondary to after-load reduction.
No takes yet. Share an insight, caveat, or question.
Tweddel et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: